<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="25" ids="22693">Barbiturates</z:chebi> are often utilized clinically in circumstances in which <z:e sem="disease" ids="C0151740" disease_type="Disease or Syndrome" abbrv="">elevated intracranial pressure</z:e> is expected </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, the mechanism of action of <z:chebi fb="25" ids="22693">barbiturates</z:chebi> was examined in dogs with intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> induced by injecting autogenous incubated blood into the chiasmatic cistern </plain></SENT>
<SENT sid="2" pm="."><plain>Intracranial pressure and systemic blood pressure were continuously monitored </plain></SENT>
<SENT sid="3" pm="."><plain>A single bilateral administration of powdered <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> (2 mg and 0.4 mg) in experimental animals and solid d-<z:chebi fb="105" ids="17234">glucose</z:chebi> (2 mg) in control animals was given into the posterior hypothalamus, pontine reticular formation, or medullary reticular formation when intracranial pressure reached 20-30 mmHg after the blood injection--usually in 3-6 h </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> following the experimental <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> was always associated with either intracranial pressure irregularities or concomitant blood pressure variations, suggesting the presence of vasomotor instability </plain></SENT>
<SENT sid="5" pm="."><plain>Administration of both 2 mg and 0.4 mg of <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> into the medulla caused a significant (P less than 0.01) decrease of the intracranial pressure to 44 and 65% of control and stabilization of the intracranial pressure irregularities, whereas <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> given at the other sites did not </plain></SENT>
<SENT sid="6" pm="."><plain>The blood pressure was also decreased significantly (P less than 0.01) to 80 and 88% of control and the blood pressure variations were stabilized in animals after administration of <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> into the medulla, whereas in those given <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> at the other sites, it was not </plain></SENT>
<SENT sid="7" pm="."><plain>The results suggest that, in the presence of <z:e sem="disease" ids="C0151740" disease_type="Disease or Syndrome" abbrv="">elevated intracranial pressure</z:e> following experimental <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo>, the mechanisms of action of <z:chebi fb="25" ids="22693">barbiturates</z:chebi> in reducing the intracranial pressure may result from alleviation of cerebral vasomotor instability by <z:hpo ids='HP_0000716'>depression</z:hpo> of the vasomotor center of the medulla </plain></SENT>
</text></document>